Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus)

By Van Buren D.   Payne J.   Geevarghese S.   MacDonell R.   Chapman W.   Wright J.K.   Helderman J.H.   Richie R.   Pinson C.W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1401-1402

Elsevier

Access to resources Recommend Favorite

Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite

Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients

By Zylber-Katz E.   Doron D.   Granot E.  

Transplantation Proceedings, Vol. 31, Iss. 4, 1999-06 ,pp. : 1915-1917

Elsevier

Access to resources Recommend Favorite

Effect of Sandimmune Cyclosporine on Renal Blood Flow and Function in Heart Transplant Recipients

By Chung G.   Walker S.   Vadher B.   Murphy F.   Leaver N.   Banner N.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1147-1148

Elsevier

Access to resources Recommend Favorite

Estimation of mean relative bioavailability of cyclosporine sandimmune and neoral using NONMEM in renal transplant recipients

By Lee K.L.   Lee K.T.   Chung H.M.   Lin Y.P.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3526-3529

Elsevier

Access to resources Recommend Favorite